Kui Luo

机构：Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, West China Hospital of Sichuan University, Neijiang Normal University, Sichuan University of Science and Engineering · ORCID：0000-0002-3536-1485

发表论文 352 篇 · 总被引 16730 次 · h-index 78

代表论文

• Reversing adenosine-mediated immunosuppression in triple-negative breast cancer by synergistic chemo-immunotherapy via stimuli-responsive nanomedicines (2025 · EBioMedicine · 被引 39)
• Rapid amyloid-β clearance and cognitive recovery through multivalent modulation of blood–brain barrier transport (2025 · Signal Transduction and Targeted Therapy · 被引 34)
• Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics (2025 · Theranostics · 被引 30)
• Chrono-controlled hydrogel platform orchestrates metabolic reprogramming and cuproptosis-driven immune activation against triple-negative breast cancer (2025 · Biomaterials · 被引 20)
• Biomaterials nanoplatform-based tumor vaccines for immunotherapy (2025 · Bioactive Materials · 被引 13)
• A Colon-Targeted Oral Nanosystem Disrupts the Inflammatory Loop in Enteric Glia to Alleviate Ulcerative Colitis (2025 · ACS Nano · 被引 12)